NCT02239744

Brief Summary

This study aimed to evaluate whether a short-term indoor air purifier intervention improves cardiopulmonary health based on a randomized double-blind crossover trial

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 15, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
1 month until next milestone

Results Posted

Study results publicly available

December 1, 2014

Completed
Last Updated

January 13, 2016

Status Verified

January 1, 2016

Enrollment Period

2 months

First QC Date

September 7, 2014

Results QC Date

November 19, 2014

Last Update Submit

January 12, 2016

Conditions

Keywords

air pollutionair purificationinterventionrandomized controlled trialcardiovascular healthpulmonary health

Outcome Measures

Primary Outcomes (2)

  • Circulating Biomarkers

    Peripheral blood samples (5 ml) were drawn by a nurse, separated into serum and plasma, and stored at -80 ℃ within 30 minutes. We measured the levels of 14 circulating biomarkers: (1) 8 biomarkers of inflammation, including C-reactive protein (CRP), fibrinogen, P-selection, monocyte chemoattractant protein-1 (MCP-1), interleukin-1b, interleukin-6, tumor necrosis factor-α (TNF-α) and myeloperoxidase; (2) 4 biomarkers of coagulation, including soluble CD40 ligand (sCD40L), plasminogen activator inhibitor-1, tissue plasminogen activator and D-Dimer; and (3) 2 biomarkers of vasoconstriction, including endothelin-1 and angiotensin-converting enzyme.

    Blood samples were drawn within one hour after the intervention, and lab analysis was completed in the next 10 days

  • Lung Function

    A respiratory physician measured forced vital capacity, forced expiratory volume in 1 second and peak expiratory flow of each participant using the JAEGER Masterlab equipment (Würzburg, Germany) that meets the American Thoracic Society criteria. The volume signal was calibrated at least once on a testing day with a 3.0 L syringe connected to the pneumotachograph in accordance with the manufacturers' recommendations. We instructed participants to perform at least three forced expiratory lung function maneuvers in order to obtain a minimum of two acceptable and reproducible values, and we recorded the best results.

    Within 1 hour after the end of the two-day intervention

Secondary Outcomes (2)

  • Blood Pressure

    Within one hour after the 2-day intervention

  • Fractional Exhaled Nitric Oxide

    within 1 hour after the two-day intervention

Study Arms (2)

True air purification

EXPERIMENTAL

One group of subjects used an intervention of true air purifiers placed in the center of the room.

Behavioral: Air purifiers

Sham air purification

SHAM COMPARATOR

This group of subjects used an intervention of sham air purifiers under the same conditions with true purifiers with the only difference being removal of the filter gauze in the sham purifiers.

Behavioral: Air purifiers

Interventions

Air purifiersBEHAVIORAL

The 10 dormitory rooms were randomized into two groups of 5 rooms each. One group used an air purifier placed in the center of the room for 48 hours corresponding to one weekend, followed by a 2-week washout period, and another 48 hours of using a sham air purifier under the same conditions. The other group simply reversed the order in which the real and sham air purifiers were used. All rooms used the same qualified air purifiers (model FAP04, 3M Filtrete), with the only difference being removal of the filter gauze in the sham purifiers. The air pollution auto-sensing feature of air purifiers was disabled in both groups. All participants and research staff were blinded to the group assignment. We requested all participants to stay in their dormitory room with the windows/doors closed throughout each 48-hour intervention period.

Also known as: Air filtration
Sham air purificationTrue air purification

Eligibility Criteria

Age18 Years - 26 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy college students aged between 18 and 26
  • All the subjects should stay indoor almost the entire time, and stayed within the central urban area of shanghai during the wash-out period.

You may not qualify if:

  • current smokers or ever smokers
  • chronic respiratory diseases
  • chronic cardiovascular diseases
  • acute infections
  • medication use in recent one month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Environmental Health, School of Public Health, Fudan University

Shanghai, Shanghai Municipality, 200032, China

Location

Related Publications (1)

  • Chen R, Zhao A, Chen H, Zhao Z, Cai J, Wang C, Yang C, Li H, Xu X, Ha S, Li T, Kan H. Cardiopulmonary benefits of reducing indoor particles of outdoor origin: a randomized, double-blind crossover trial of air purifiers. J Am Coll Cardiol. 2015 Jun 2;65(21):2279-87. doi: 10.1016/j.jacc.2015.03.553.

MeSH Terms

Conditions

InflammationThrombosis

Interventions

Air Filters

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

FiltrationChemistry Techniques, AnalyticalInvestigative TechniquesEquipment and Supplies

Limitations and Caveats

The study only included 35 participants in 10 rooms, we might therefore have missed some potentially important but modest differences due to the relatively small sample size.

Results Point of Contact

Title
Dr. Haidong Kan
Organization
Department of Environmental Health, School of Public Health, Fudan University

Study Officials

  • Haidong Kan, PhD

    School of Public Health,Fudan University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD and Professor

Study Record Dates

First Submitted

September 7, 2014

First Posted

September 15, 2014

Study Start

September 1, 2014

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

January 13, 2016

Results First Posted

December 1, 2014

Record last verified: 2016-01

Locations